Mogito Open Access Journals of Clinical Trials and Therapeutics (MJCTT)
To celebrate the launch of MJCTT, the first 10 accepted manuscripts will be published free of charge.
Submit now and enjoy open access publishing at no cost.
👉 mjctt@mogitojournals.org
Mogito Open Access Journals of Clinical Trials and Therapeutics (MJCTT)
We are delighted to announce the launch of the Mogito Open Access Journals of Clinical Trials and Therapeutics (MJCTT)—a newly established platform that has been created to advance research, development, and innovation within the fields of clinical trials and therapeutic sciences. Through this initiative, a global and multilingual exchange of scientific knowledge is actively being fostered by offering an open, transparent, and inclusive environment for researchers, clinicians, and pharmaceutical scientists to share their work.
As the foundation of our editorial board is being formed and preparations for accepting manuscript submissions are underway, expressions of interest are warmly welcomed from scholars, clinical trial investigators, and academic collaborators. By contributing your expertise—whether as an editorial board member, peer reviewer, or future author—you will be playing a vital role in shaping a journal that is guided by integrity, accessibility, and a commitment to scientific excellence.
Ultimately, through collaborative effort and shared vision, Mogito Open Access Journals of Clinical Trials and Therapeutics (MJCTT) is poised to become a trusted voice in clinical research and therapeutic advancement—where impactful science is made freely accessible to all.
Our Mission
At Mogito Open Access Journals of Clinical Trials and Therapeutics (MJCTT), our mission is to redefine how clinical trials are communicated and consumed. We believe that therapeutics evolve not only in the lab but also in policy, in practice, and in partnership with patients.
Call for Editorial Board Members, Reviewers, and Manuscript Submission
Mogito Open Access Journals of Clinical Trials and Therapeutics (MJCTT) is pleased to extend an invitation to dedicated professionals in the fields of clinical trials, therapeutics, and pharmaceutical research to become part of a newly launched, high-impact open-access platform. Through your participation, a collaborative and globally accessible space for scientific advancement can be shaped.
At this stage, the following contributions are especially welcomed:
🟠Editorial Board Members – Individuals with proven expertise in clinical research, therapeutic development, or drug evaluation are encouraged to be considered for editorial roles. As part of the board, responsibilities will include guiding the journal’s academic direction, upholding publication standards, and supporting a fair and transparent peer-review process.
🟠Peer Reviewers – Professionals with relevant experience are being sought to assist in maintaining the integrity and quality of published work. Reviews will be expected to be both timely and constructive, thereby contributing to the credibility of each issue.
🟠Manuscript Submissions – Original research articles, study protocols, clinical trial reports, and review papers are now being accepted from researchers worldwide. Multilingual submissions will be welcomed, as MJCTT aims to reflect the diversity of global clinical practices and therapeutic research.
By joining Mogito Open Access Journals of Clinical Trials and Therapeutics (MJCTT)—either as an editorial board member, a reviewer, or a contributing author—your expertise can play a vital role in establishing a journal dedicated to open science, innovation, and patient-centered care.
👉 To express interest or learn more, please reach out to us at:
[editor_mjctt@mogitojournals.org]
Ready to Publish Your Research
We’re here to guide you through every step of your publishing journey—from submission to global reach..
Let’s advance knowledge and discovery—together.
When connected with us, you aren’t growing your business alone. We have your back and put in our best to contribute to the growth of your entire team and organization. So, if you are “When you publish with us, you’re not navigating the process alone. Our editorial team is committed to supporting you through peer review, publication, and global dissemination. If you’re looking for the right platform to share your research, enhance visibility, and make a meaningful impact—Mogito is here for you.”
“We are passionate about scholarly publishing and committed to helping researchers share their work with the world. As your trusted publishing partner, we ensure a seamless, transparent, and supportive process from submission to publication.”
